zeitschrift für gastroenterologie
140285;130265;140295
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Zeitschrift für Gastroenterologie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Information
Table of Contents
Imprint
Media
Authors
Instructions for Authors
Forms
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Societies
Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten mit Sektion Gastroenterologische Endoskopie
Österreichische Gesellschaft für Gastroenterologie und Hepatologie
Hungarian Society of Gastroenterology
Job Board
Job Opportunities
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Issues
Current Issue
Free Sample Issue (01/2024)
Related Journals
Gastroenterologie up2date
Endoscopy
Endoskopie heute
DMW - Deutsche Medizinische Wochenschrift
Related Books
Innere Medizin: Gastroenterologie
Innere Medizin: Allgemein
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Y
Z
Abada, P
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Abreu, M
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Adolph, TE
Gastric banding-associated weight loss diminishes hepatic
Tsukushi
expression
Agostino, M
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Aigner, E
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Alcohol consumption and the risk for colorectal adenoma
Should colonoscopy screening recommendations be sex-specific and age adjusted?
Alber, H
Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new Multidisciplinary Diagnostic Criteria
Albrecht, U
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Andreone, P
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Angela, A
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Anja, G
Pregnancy Outcomes in Women with Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis Treated with Ustekinumab
Apostol, S
Endoskopische Raritäten - eine kleine Sammlung.
Prävalenz des Folatmangels bei Patient*innen mit chron. entzündlichen Darmerkrankungen und Daten zur Effektivität eines Dauer-Substitutionsschemas.
Arasaradnam, R
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Armuzzi, A
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Arrisi, P
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
Bachmayer, S
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Alcohol consumption and the risk for colorectal adenoma
Baiges, A
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Balcar, L
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Baron, D
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Baron-Stefaniak, J
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Bauer, D
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Bauer, DJ
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Baumann-Durchschein, F
Ein seltener und lange Zeit unklarer Fall: IgG4 - assoziierte Ösophagitis
Beer, A
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Beliveau, V
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Beraza, N
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Bergheim, I
Sarcopenia and liver cirrhosis- Comparison of the
European Working group on Sarcopenia criteria
2010 and 2019
Bergmeister, P
Duale Biologikatherapie bei CED - eine weitere Option?
Bernhofer, S
The gastrointestinal bleeding registry at the University Hospital St. Pölten, Austria-A prospective evaluation
Binter, T
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Blesl, A
Ein seltener und lange Zeit unklarer Fall: IgG4 - assoziierte Ösophagitis
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Boruvka, A
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
Bota, S
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Challenges in hepatitis C elimination despite highly effective antiviral agents - experience of a tertiary Hepatology center
Endoscopic ultrasound (EUS) in elderly patients
Usefullness of Endoscopic Ultrasound (EUS) in early biliary pancreatitis without cholestasis on conventional imaging
Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new Multidisciplinary Diagnostic Criteria
Comparison between accuracy of flexible nitinol fine needle aspiration(FNA) and fine needle biopsy(FNB) endoscopic ultrasound (EUS) needles for solid pancreatic masses-retrospective bicentric analysis
Bleeding risk after endosonographic (EUS) puncture of pancreas masses- comparison between aspiration (FNA) and biopsy (FNB) fine needles
Incidence of sedation-related complications and risk factors associated with non-anesthesiologist administration of sedation in endoscopic ultrasound (EUS)- prospective study
RGB Image analysis of pancreatic mass-elastographies in endoscopic ultrasound (EUS) can predict malignancy- a pilot study
Bowlus, CL
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Bucsics, T
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Burghart, L
Features of the portal hypertensive syndrome in patients with advanced PBC
Carmen, S
Endoskopische Raritäten - eine kleine Sammlung.
Chromy, D
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Danese, S
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Daniele, B
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Danzinger, D
Endoskopische Raritäten - eine kleine Sammlung.
Prävalenz des Folatmangels bei Patient*innen mit chron. entzündlichen Darmerkrankungen und Daten zur Effektivität eines Dauer-Substitutionsschemas.
Daperno, M
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Datz, C
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Alcohol consumption and the risk for colorectal adenoma
Should colonoscopy screening recommendations be sex-specific and age adjusted?
Dejaco, C
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Desbalmes, C
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Dibold, A
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Dignass, A
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
di Vora, K
The use of and knowledge about proton pump inhibitors in the general population of Austria
Drenth, JP
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Dumoulin, F
Bislang vernachlässigte Parameter bei EPE, EMR und ESD und die Rolle der Endoskopischen Submukosa Resektion (ESR)
Eberl, T
Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification
Eckel, H
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Eckhardt, G
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Effenberger, M
Gastric banding-associated weight loss diminishes hepatic
Tsukushi
expression
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Eherer, A
Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte
Ein seltener und lange Zeit unklarer Fall: IgG4 - assoziierte Ösophagitis
Eibisberger, M
Sarcopenia and liver cirrhosis- Comparison of the
European Working group on Sarcopenia criteria
2010 and 2019
Eigenbauer, E
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Eisterer, W
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Engertsberger, L
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Enrich, B
Gastric banding-associated weight loss diminishes hepatic
Tsukushi
expression
Ercole, E
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Erhart, L
Chronic pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten
Acute pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten.
Essler, G
Endoscopic ultrasound (EUS) in elderly patients
Usefullness of Endoscopic Ultrasound (EUS) in early biliary pancreatitis without cholestasis on conventional imaging
Comparison between accuracy of flexible nitinol fine needle aspiration(FNA) and fine needle biopsy(FNB) endoscopic ultrasound (EUS) needles for solid pancreatic masses-retrospective bicentric analysis
Bleeding risk after endosonographic (EUS) puncture of pancreas masses- comparison between aspiration (FNA) and biopsy (FNB) fine needles
Incidence of sedation-related complications and risk factors associated with non-anesthesiologist administration of sedation in endoscopic ultrasound (EUS)- prospective study
RGB Image analysis of pancreatic mass-elastographies in endoscopic ultrasound (EUS) can predict malignancy- a pilot study
Etz, A
Respiratorische Infekte in den nächsten 14 Tagen unter Teilnehmern eines zweitägigen medizinischen Treffens
Eva, O
Endoskopische Raritäten - eine kleine Sammlung.
Farin, G
Bislang vernachlässigte Parameter bei EPE, EMR und ESD und die Rolle der Endoskopischen Submukosa Resektion (ESR)
Feagan, B
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT
Feichtenschlager, T
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Feldbacher, N
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Fibroscan® probe selection for lean adults
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis
Felder, T
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Feldman, A
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Ferenci, P
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Ferlitsch, M
Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program
Ferrusquía-Acosta, J
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Fickert, P
Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency
Fink, N
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Finn, R
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Flatscher, K
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Challenges in hepatitis C elimination despite highly effective antiviral agents - experience of a tertiary Hepatology center
Forns, X
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Frick, A
Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification
Fuchs, CD
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Fuchssteiner, H
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Fürschuß, L
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency
Galle, P
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
García-Pagán, J
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Gartner, J
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Gattringer, D
Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Gaumann, A
Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification
Gaya, D
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Gerner, R
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Glöckler, M
Endoskopischer Verschluss einer Anastomosendehiszenz nach Hemikolektomie mit dem OverStitch™ Endoscopic Suturing System
Glodny, B
The
PNPLA3
G-allele is common in patients with HCC but does not affect tumor characteristics and tumor biology
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Grabherr, F
Gastric banding-associated weight loss diminishes hepatic
Tsukushi
expression
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Graf, R
Endoskopische Raritäten - eine kleine Sammlung.
Grander, C
Gastric banding-associated weight loss diminishes hepatic
Tsukushi
expression
Graziadei, I
DAA therapy for chronic hepatitis c infection: risk factors for nonadherence and relapse
Graziani-Weiss, W
Konsekutive rechtsanhängige fachspezifische Komplikationen über 5 Jahrean einer Abteilung für Gastroenterologie und Hepatologie
Gremmel, S
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Groechenig, H
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Grossmann, V
Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification
Grund, K
Bislang vernachlässigte Parameter bei EPE, EMR und ESD und die Rolle der Endoskopischen Submukosa Resektion (ESR)
Interventionsfähiges Trainingsmodell für die flexible Endoskopie bei postoperativ veränderter Anatomie des oberen GI-Traktes
Gschwantler, M
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Gutic, E
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Haas, T
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Hackl, M
Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new Multidisciplinary Diagnostic Criteria
Haens, G
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Halilbasic, E
Features of the portal hypertensive syndrome in patients with advanced PBC
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Haltmayer, H
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Hartl, L
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Haselmann, C
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Hempel, D
Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification
Hempel, L
Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification
Henninger, B
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Hernández-Gea, V
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Hinterberger, A
Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program
Hisamatsu, T
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Hofer, B
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Högenauer, C
Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte
Hoppe, R
Endoskopische Raritäten - eine kleine Sammlung.
Horvath, A
Where have all the women gone? - Die Repräsentation von Frauen in der Gastroenterologie und Hepatologie in Österreich
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Fibroscan® probe selection for lean adults
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis
Horvath A, Stadlbauer V
The use of and knowledge about proton pump inhibitors in the general population of Austria
Huber-Schönauer, U
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Alcohol consumption and the risk for colorectal adenoma
Should colonoscopy screening recommendations be sex-specific and age adjusted?
Hucke, F
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Challenges in hepatitis C elimination despite highly effective antiviral agents - experience of a tertiary Hepatology center
Ikeda, M
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Jachs, M
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Jaschke, N
Gastric banding-associated weight loss diminishes hepatic
Tsukushi
expression
Jeschke, K
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Johanns, J
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Jörg-Streller, M
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Kallab, T
Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study
Kammerlander, A
Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program
Karall, D
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Kircher, B
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Kirchgatterer, A
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Kloucek, W
Chronic pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten
Koch, K
Interventionsfähiges Trainingsmodell für die flexible Endoskopie bei postoperativ veränderter Anatomie des oberen GI-Traktes
Koch, R
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Kofler, J
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Komarova, I
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis
König, K
Endoskopische Raritäten - eine kleine Sammlung.
Konrad, J
Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte
Kozbial, K
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Kramer, L
Endoskopische Raritäten - eine kleine Sammlung.
Prävalenz des Folatmangels bei Patient*innen mit chron. entzündlichen Darmerkrankungen und Daten zur Effektivität eines Dauer-Substitutionsschemas.
Kronenberg, F
Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study
Kucharzik, T
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Kudo, M
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Kutilek, M
Comparison between accuracy of flexible nitinol fine needle aspiration(FNA) and fine needle biopsy(FNB) endoscopic ultrasound (EUS) needles for solid pancreatic masses-retrospective bicentric analysis
Bleeding risk after endosonographic (EUS) puncture of pancreas masses- comparison between aspiration (FNA) and biopsy (FNB) fine needles
Incidence of sedation-related complications and risk factors associated with non-anesthesiologist administration of sedation in endoscopic ultrasound (EUS)- prospective study
Kutschera, M
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Lahaye, M
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Laimer, M
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Lamina, C
Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study
Lang, T
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Lange-Asschenfeldt, B
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Längle, J
Der NAD+ salvage pathway in NK-Zellen bei intestinaler Inflammation
Le Bars, M
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Leber, B
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis
Lens, S
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Leong, W
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Lesnik, G
Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new Multidisciplinary Diagnostic Criteria
Li, N
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Liberman, A
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Lim, H
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Lin, C
Pregnancy Outcomes in Women with Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis Treated with Ustekinumab
Ling, K
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Llovet, J
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Löwenberg, M
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Ludwiczek, O
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Lukas, M
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Maaser, C
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
MacConell, L
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Macheiner, S
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Machkova, N
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Machrainer, S
Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Maconi, G
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Madl, C
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Magaz, M
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Magro, F
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Maieron, A
The gastrointestinal bleeding registry at the University Hospital St. Pölten, Austria-A prospective evaluation
Comparison between accuracy of flexible nitinol fine needle aspiration(FNA) and fine needle biopsy(FNB) endoscopic ultrasound (EUS) needles for solid pancreatic masses-retrospective bicentric analysis
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Bleeding risk after endosonographic (EUS) puncture of pancreas masses- comparison between aspiration (FNA) and biopsy (FNB) fine needles
Incidence of sedation-related complications and risk factors associated with non-anesthesiologist administration of sedation in endoscopic ultrasound (EUS)- prospective study
Chronic pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten
Acute pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten.
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Majcher, B
Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program
Malecha, ES
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Mandorfer, M
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Features of the portal hypertensive syndrome in patients with advanced PBC
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Marano, C
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Marculescu, R
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Mariño, Z
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Marschall, H
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Massl, S
Endoskopische Raritäten - eine kleine Sammlung.
Mattes, S
Chronic pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten
Acute pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten.
Mauel, C
Vorsorgekoloskopie und Sedierung im Spannungsfeld zwischen Leitlinie und Praxis im ländlichen Raum
Mauler, H
Endoskopische Raritäten - eine kleine Sammlung.
Mayer, A
The gastrointestinal bleeding registry at the University Hospital St. Pölten, Austria-A prospective evaluation
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Mayr, L
Gastric banding-associated weight loss diminishes hepatic
Tsukushi
expression
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Megymorecz, S
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Meischl, T
The impact of novel systemic treatment options on the outcome of patients with hepatocellular carcinoma
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Regorafenib dosing in patients with advanced hepatocellular carcinoma (HCC) - a retrospective real-world experience
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Metter, K
Bislang vernachlässigte Parameter bei EPE, EMR und ESD und die Rolle der Endoskopischen Submukosa Resektion (ESR)
Meyer, C
Where have all the women gone? - Die Repräsentation von Frauen in der Gastroenterologie und Hepatologie in Österreich
Miehsler, W
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Miksch, S
Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Mitrovits, N
Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome
Mlitz, V
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Morimot, M
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Moschen, A
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Moschen, AR
Der NAD+ salvage pathway in NK-Zellen bei intestinaler Inflammation
Moser, G
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Moser, P
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Mothes, B
Interventionsfähiges Trainingsmodell für die flexible Endoskopie bei postoperativ veränderter Anatomie des oberen GI-Traktes
Müller, CJ
The impact of novel systemic treatment options on the outcome of patients with hepatocellular carcinoma
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Regorafenib dosing in patients with advanced hepatocellular carcinoma (HCC) - a retrospective real-world experience
Mussnig, B
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Nachbaur, D
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Nazar, M
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Negrean, I
Fibroscan® probe selection for lean adults
Nevens, F
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Ni, L
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Niederreiter, M
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency
Niederseer, D
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Alcohol consumption and the risk for colorectal adenoma
Should colonoscopy screening recommendations be sex-specific and age adjusted?
Nigl, K
Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Novacek, G
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
O´Brien, C
Pregnancy Outcomes in Women with Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis Treated with Ustekinumab
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Oberacher, H
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Oberleitner, C
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Obwegeser, I
Duale Biologikatherapie bei CED - eine weitere Option?
Oh, YS
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT
Olivas, P
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Oostingh, G
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Pachofszky, T
Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome
Pai, RK
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
Painsipp, J
DAA therapy for chronic hepatitis c infection: risk factors for nonadherence and relapse
Panaccione, R
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Panés, J
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Panzer, M
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Papay, P
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Paternostro, R
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Paulweber, B
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Paumgartner, G
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Peck-Radosavljevic, M
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Challenges in hepatitis C elimination despite highly effective antiviral agents - experience of a tertiary Hepatology center
Endoscopic ultrasound (EUS) in elderly patients
Usefullness of Endoscopic Ultrasound (EUS) in early biliary pancreatitis without cholestasis on conventional imaging
Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new Multidisciplinary Diagnostic Criteria
Comparison between accuracy of flexible nitinol fine needle aspiration(FNA) and fine needle biopsy(FNB) endoscopic ultrasound (EUS) needles for solid pancreatic masses-retrospective bicentric analysis
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Bleeding risk after endosonographic (EUS) puncture of pancreas masses- comparison between aspiration (FNA) and biopsy (FNB) fine needles
Incidence of sedation-related complications and risk factors associated with non-anesthesiologist administration of sedation in endoscopic ultrasound (EUS)- prospective study
RGB Image analysis of pancreatic mass-elastographies in endoscopic ultrasound (EUS) can predict malignancy- a pilot study
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Pencek, R
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Penz, D
Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program
Peters, P
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Duale Biologikatherapie bei CED - eine weitere Option?
Peyrin-Biroulet, L
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Pfeifer, B
Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study
Pfister, A
Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Der NAD+ salvage pathway in NK-Zellen bei intestinaler Inflammation
Pfisterer, N
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Pichler, G
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Pinte, Mr
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Pinter, M
The impact of novel systemic treatment options on the outcome of patients with hepatocellular carcinoma
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Regorafenib dosing in patients with advanced hepatocellular carcinoma (HCC) - a retrospective real-world experience
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Piribauer, M
Duale Biologikatherapie bei CED - eine weitere Option?
Piringer, P
Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Pirker, R
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Platzer, R
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Pollheimer, M
Ein seltener und lange Zeit unklarer Fall: IgG4 - assoziierte Ösophagitis
Pomej, K
The impact of novel systemic treatment options on the outcome of patients with hepatocellular carcinoma
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Regorafenib dosing in patients with advanced hepatocellular carcinoma (HCC) - a retrospective real-world experience
Portugaller, RH
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency
Posch,
Fibroscan® probe selection for lean adults
Primas, C
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Przysiecki, N
Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Püspök, A
Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome
Quehenberger, P
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Raeven, P
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Rainer, F
Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Rau, K
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Rauter, M
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Razpotnik, M
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Challenges in hepatitis C elimination despite highly effective antiviral agents - experience of a tertiary Hepatology center
Endoscopic ultrasound (EUS) in elderly patients
Usefullness of Endoscopic Ultrasound (EUS) in early biliary pancreatitis without cholestasis on conventional imaging
Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new Multidisciplinary Diagnostic Criteria
Comparison between accuracy of flexible nitinol fine needle aspiration(FNA) and fine needle biopsy(FNB) endoscopic ultrasound (EUS) needles for solid pancreatic masses-retrospective bicentric analysis
Bleeding risk after endosonographic (EUS) puncture of pancreas masses- comparison between aspiration (FNA) and biopsy (FNB) fine needles
Incidence of sedation-related complications and risk factors associated with non-anesthesiologist administration of sedation in endoscopic ultrasound (EUS)- prospective study
RGB Image analysis of pancreatic mass-elastographies in endoscopic ultrasound (EUS) can predict malignancy- a pilot study
Reiberger, T
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Features of the portal hypertensive syndrome in patients with advanced PBC
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Reichmayr, M
Endoskopische Raritäten - eine kleine Sammlung.
Prävalenz des Folatmangels bei Patient*innen mit chron. entzündlichen Darmerkrankungen und Daten zur Effektivität eines Dauer-Substitutionsschemas.
Reicht, G
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Reider, S
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Reider, SJ
Der NAD+ salvage pathway in NK-Zellen bei intestinaler Inflammation
Remetic, J
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Riedl, F
The gastrointestinal bleeding registry at the University Hospital St. Pölten, Austria-A prospective evaluation
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Rowbotham, D
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Rubin, DT
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT
Ruhaltinger, S
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Sandborn, W
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Sands, B
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Santler, G
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Scalori, A
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
Scarpatetti, M
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Schaefer, B
The
PNPLA3
G-allele is common in patients with HCC but does not affect tumor characteristics and tumor biology
Schäfer, B
DAA therapy for chronic hepatitis c infection: risk factors for nonadherence and relapse
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study
Scharnagl, H
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Schaufler, D
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Scheiner, B
The impact of novel systemic treatment options on the outcome of patients with hepatocellular carcinoma
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Regorafenib dosing in patients with advanced hepatocellular carcinoma (HCC) - a retrospective real-world experience
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Scherfler, C
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Scherl, A
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
Scherl, E
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Schippinger, W
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Schlager, H
Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte
Ein seltener und lange Zeit unklarer Fall: IgG4 - assoziierte Ösophagitis
Schleischitz, A
Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome
Schmidbauer, C
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Schmidt, R
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Schöfl, R
Respiratorische Infekte in den nächsten 14 Tagen unter Teilnehmern eines zweitägigen medizinischen Treffens
Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Konsekutive rechtsanhängige fachspezifische Komplikationen über 5 Jahrean einer Abteilung für Gastroenterologie und Hepatologie
Scholl-Bürg, Si
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Schönherr, E
The
PNPLA3
G-allele is common in patients with HCC but does not affect tumor characteristics and tumor biology
Schreiner, C
Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Schubert, R
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Schütz, A
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Schwabl, P
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Features of the portal hypertensive syndrome in patients with advanced PBC
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Schwaighofer, H
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Schwanke, C
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Schwarz, M
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Schwärzler, J
Gastric banding-associated weight loss diminishes hepatic
Tsukushi
expression
Schweizer, U
Interventionsfähiges Trainingsmodell für die flexible Endoskopie bei postoperativ veränderter Anatomie des oberen GI-Traktes
Schwenoha, K
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Sebastian, B
Should colonoscopy screening recommendations be sex-specific and age adjusted?
Seemann, C
Endoskopische Raritäten - eine kleine Sammlung.
Seidl, M
Endoskopischer Verschluss einer Anastomosendehiszenz nach Hemikolektomie mit dem OverStitch™ Endoscopic Suturing System
Semlitsch, S
Respiratorische Infekte in den nächsten 14 Tagen unter Teilnehmern eines zweitägigen medizinischen Treffens
Semmler, G
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Alcohol consumption and the risk for colorectal adenoma
Should colonoscopy screening recommendations be sex-specific and age adjusted?
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Sheri, V
Pregnancy Outcomes in Women with Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis Treated with Ustekinumab
Shiffman, ML
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Shinozaki, K
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Siebenbrunner, B
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Siegmund, K
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Simbrunner, B
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Features of the portal hypertensive syndrome in patients with advanced PBC
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Sloan, S
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Solfrank, B
Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification
Spindelböck, W
Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte
Stadlbauer, V
Sarcopenia and liver cirrhosis- Comparison of the
European Working group on Sarcopenia criteria
2010 and 2019
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis
Stadlbauer-Köllner, V
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Where have all the women gone? - Die Repräsentation von Frauen in der Gastroenterologie und Hepatologie in Österreich
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Fibroscan® probe selection for lean adults
Stadlmann, A
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Stahlmann, M
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Stangassinger, L
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Stättermayer, A
The gastrointestinal bleeding registry at the University Hospital St. Pölten, Austria-A prospective evaluation
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Stättermayer, AF
Features of the portal hypertensive syndrome in patients with advanced PBC
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Stättermayer, M
The gastrointestinal bleeding registry at the University Hospital St. Pölten, Austria-A prospective evaluation
Stauber, R
Fibroscan® probe selection for lean adults
Steindl-Munda, P
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Steiner, E
Chronic pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten
Acute pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten.
Steiner, P
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Steinwender, M
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Stift, J
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Stimakovits, J
Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome
Stojakovic, T
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Stradner, M
Ein seltener und lange Zeit unklarer Fall: IgG4 - assoziierte Ösophagitis
Strasser, M
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Strebinger, G
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Streit, A
Fibroscan® probe selection for lean adults
Svoboda, C
Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome
Tardelli, M
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Tevini, J
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Texler, B
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Tikhonov, I
Pregnancy Outcomes in Women with Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis Treated with Ustekinumab
Tilg, H
Gastric banding-associated weight loss diminishes hepatic
Tsukushi
expression
The
PNPLA3
G-allele is common in patients with HCC but does not affect tumor characteristics and tumor biology
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Der NAD+ salvage pathway in NK-Zellen bei intestinaler Inflammation
Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Tillinger, W
Endoskopischer Verschluss einer Anastomosendehiszenz nach Hemikolektomie mit dem OverStitch™ Endoscopic Suturing System
Tobiasch, M
DAA therapy for chronic hepatitis c infection: risk factors for nonadherence and relapse
Tole, S
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT
Traub, J
Sarcopenia and liver cirrhosis- Comparison of the
European Working group on Sarcopenia criteria
2010 and 2019
Trauner, M
The impact of novel systemic treatment options on the outcome of patients with hepatocellular carcinoma
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Regorafenib dosing in patients with advanced hepatocellular carcinoma (HCC) - a retrospective real-world experience
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Features of the portal hypertensive syndrome in patients with advanced PBC
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Tschoner, A
Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie
Turon, F
SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease
Tyrrell, H
ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT
Ubl, N
Respiratorische Infekte in den nächsten 14 Tagen unter Teilnehmern eines zweitägigen medizinischen Treffens
Urak, C
Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Challenges in hepatitis C elimination despite highly effective antiviral agents - experience of a tertiary Hepatology center
Incidence of sedation-related complications and risk factors associated with non-anesthesiologist administration of sedation in endoscopic ultrasound (EUS)- prospective study
van Erpecum, K
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Vargas, V
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis
Vermeire, S
Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Vermeren, S
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis
Viveiros, A
The
PNPLA3
G-allele is common in patients with HCC but does not affect tumor characteristics and tumor biology
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study
Vogelsang, H
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT
Wahlström, A
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Waldhoer, T
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Waldmann, E
Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program
Wang, C
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Watschinger, C
Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Weber-Eibel, J
Endoscopic ultrasound (EUS) in elderly patients
Usefullness of Endoscopic Ultrasound (EUS) in early biliary pancreatitis without cholestasis on conventional imaging
Comparison between accuracy of flexible nitinol fine needle aspiration(FNA) and fine needle biopsy(FNB) endoscopic ultrasound (EUS) needles for solid pancreatic masses-retrospective bicentric analysis
Bleeding risk after endosonographic (EUS) puncture of pancreas masses- comparison between aspiration (FNA) and biopsy (FNB) fine needles
Incidence of sedation-related complications and risk factors associated with non-anesthesiologist administration of sedation in endoscopic ultrasound (EUS)- prospective study
RGB Image analysis of pancreatic mass-elastographies in endoscopic ultrasound (EUS) can predict malignancy- a pilot study
Weilnböck, E
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Wenzl, H
The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Wernly, B
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Alcohol consumption and the risk for colorectal adenoma
Should colonoscopy screening recommendations be sex-specific and age adjusted?
Wernly, S
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Alcohol consumption and the risk for colorectal adenoma
Should colonoscopy screening recommendations be sex-specific and age adjusted?
Wichmann, D
Interventionsfähiges Trainingsmodell für die flexible Endoskopie bei postoperativ veränderter Anatomie des oberen GI-Traktes
Widau, R
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Wieland, T
Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification
Wilkens, R
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy
Wille, B
Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Wimmer, P
Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new Multidisciplinary Diagnostic Criteria
Winder, T
Duale Biologikatherapie bei CED - eine weitere Option?
Wittmann, A
Acute pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten.
Wolfrum, C
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Wolfrum, S
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling
Wöran, K
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy
Wurz, M
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Yen, C
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Yoshikawa, R
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Zandanell, S
The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Zavarsky, C
Respiratorische Infekte in den nächsten 14 Tagen unter Teilnehmern eines zweitägigen medizinischen Treffens
Zeiser, R
Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.
Zhang, H
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Zhou, Y
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension
Zhu, A
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Zoller, H
DAA therapy for chronic hepatitis c infection: risk factors for nonadherence and relapse
The
PNPLA3
G-allele is common in patients with HCC but does not affect tumor characteristics and tumor biology
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study
Zollner, A
Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Der NAD+ salvage pathway in NK-Zellen bei intestinaler Inflammation